Quantum BioPharma is trading 5% down at $2.84, extending a volatile pattern amid continued technical weakness and profit-taking.
- The decline occurs despite strength in the broader biotech sector, suggesting the move is driven by internal technical factors rather than industry trends.
- There is no fresh company-specific news to account for the drop, which follows a period of recent selling pressure and a brief technical bounce.